Validation of the Brazilian version of the neurological fatigue index for multiple sclerosis

Autor: Josiane Lopes, Edson Lopes Lavado, Damacio Ramón Kaimen-Maciel

Publikováno v: Arquivos de Neuro-Psiquiatria, Vol 74, Iss 4, Pp 320-328 (2016)

ABSTRACT The Neurological Fatigue Index for Multiple Sclerosis (NFI-MS) is a new fatigue assessment instrument. The aim of this study was to cross-culturally adapt and assess the psychometric properties of the Brazilian version of the NFI-MS (NFI-MS/

Externí odkaz: https://doaj.org/article/b5e3bcec701b488da084329be55563ee

[Untitled]

Autor: Yára Dadalti Fragoso, Soniza Vieira Alves-Leon, Walter Oleschko Arruda, Margarete de Jesus Carvalho, Elizabeth Regina Comini-Frota, Éber Castro Corrêa, Maria Lucia Brito Ferreira, Paulo Diniz da Gama, Sidney Gomes, Marcus Vinicius Magno Gonçalves, Damacio Ramón Kaimen-Maciel, Maria Fernanda Mendes, Rogerio Rizo Morales, Andre Muniz, Pedro Rippel Salgado, Heloisa Helena Ruocco, Livia Brito Bezerra de Albuquerque, Joseph Bruno Bidin Brooks, Letícia Fêzer, Sergio Georgetto, Josiane Lopes, Fabíola Rachid Malfetano, Isabella D'Andrea Meira, Celso Luis Silva Oliveira, Francisco Tomaz Meneses de Oliveira, Fabiana Safanelli, Massaco Satomi

Publikováno v: Arquivos de Neuro-Psiquiatria, Vol 71, Iss 3, Pp 137-141 (2013)

Objective To assess the prevalence and the profile of adverse events (AE) of natalizumab in patients with multiple sclerosis (MS). Methods Data collection from neurologists attending to patients with MS at specialized units in Bra

Externí odkaz: https://doaj.org/article/066c2247473b4a5b8af6ac9f4fa33e26

Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous system

Autor: Milena Sales Pitombeira, Denis Bernardi Bichuetti, Ana Beatriz Ayroza Galvão Ribeiro Gomes, Guilherme Sciascia do Olival, Sidney Gomes, Tarso Adoni, Robson Lázaro, Doralina Guimarães Brum, Giordani Rodrigues dos Passos, Fernando Elias Borges, Maria Cecilia de Vecino, Taysa Alexandrino Gonsalves Jube Ribeiro, Felipe von Glehn, Carlos Bernardo Tauil, Thereza Cristina d’Avila Winckler, Soniza Vieira Alves-Leon, Damacio Ramón Kaimen-Maciel, Marcus Goncalves, Heloisa Helena Ruocco, T. Junqueira, Nise Alessandra de Carvalho Sousa, Mateus Boaventura, Guilherme Diogo Silva, Antonio Pereira Gomes Neto, Claudia Ferreira Vasconcelos, Maria Lucia Vellutini Pimentel, Fernando Figueira, Ana Claudia Piccolo, Marlise de Castro Ribeiro, Paulo Pereira Christo, Maria Lucia Brito Ferreira, Renata Barbosa Paolilo, Dagoberto Callegaro, Maria Fernanda Mendes, Augusto César Penalva de Oliveira, Rodrigo Barbosa Thomaz, José Arthur Costa D Almeida, Enedina Maria Lobato de Oliveira, Renata Brant De Souza Melo, Lis Campos Ferreira, Rodrigo Kleinpaul, Jefferson Becker, Bianca Etelvina Santos de Oliveira, Sérgio Monteiro de Almeida, Anderson Kuntz Grzesiuk, Simone Abrante Lucatto, Juliana Santiago-Amaral, Henry Koiti Sato, Denise Sisterolli Diniz, Daniel Lima Varela, Herval Ribeiro Soares Neto, Samira Luisa dos Apostolos Pereira, Ronaldo Maciel Dias, Alfredo Damasceno, Fabiola Rachid Malfetano, Mônica Koncke Fiuza Parolin, Francisco de Assis Aquino Gondim, Thiago Gonçalves Fukuda, Yara Dadalti Fragoso, Gutemberg Augusto Cruz Dos Santos, Leandro Cortoni Calia, Marco Aurélio Lana Peixoto, Osvaldo J. M. Nascimento

Publikováno v: Arquivos de Neuro-Psiquiatria v.79 n.11 2021
Arquivos de neuro-psiquiatria
Academia Brasileira de Neurologia
instacron:ABNEURO
Arquivos de Neuro-Psiquiatria, Vol 79, Iss 11, Pp 1049-1061 (2021)

The Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) provide recommendations in this document

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9320fad67390f869ba5ed62668d38c22
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2021001101049

Consenso expandido do BCTRIMS para o tratamento da esclerose múltipla: I. As evidências para o uso de imunossupressores, plasmaférese e transplante autólogo de células tronco

Autor: Dagoberto Callegaro, Marco Aurélio Lana-Peixoto, Marcos Aurélio Moreira, Paulo Eurípedes Marchiori, Luiz Alberto Bacheschi, Walter Oleschko Arruda, Gilberto Belisário Campos, Angelina Maria Martins Lino, Aílton Souza Melo, Fernando Coronetti Gomes da Rocha, Maria Lúcia Brito Ferreira, Luiz Ataíde Júnior, Damacio Ramón Kaimen Maciel

Publikováno v: Arquivos de Neuro-Psiquiatria, Vol 60, Iss 3B, Pp 869-874 (2002)

O tratamento da esclerose múltipla (EM) com imunossupressores teve início na década de 60. As observações laboratoriais e clínicas de que a doença tinha um caráter inflamatório induziu os clínicos a utilizarem medicamentos citostáticos e i

Externí odkaz: https://doaj.org/article/08c7edd7cda24734a6c867be8c121c88

Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis

Autor: Elaine Regina Delicato de Almeida, Isaias Dichi, Andréa Name Colado Simão, Damacio Ramón Kaimen-Maciel, Edna Maria Vissoci Reiche, Helena Kaminami Morimoto, Sayonara Rangel Oliveira, Ana Paula Kallaur, Marcell Alysson Batisti Lozovoy, Daniela Frizon Alfieri, Tamires Flauzino, Beatriz Sardinha Sabino

Publikováno v: Metabolic Brain Disease. 33:1393-1399

The aims of this study were to verify whether hyperhomocysteinemia is associated with disability progression in Multiple Sclerosis (MS) patients and whether TNF pathways and cellular adhesion molecules (CAM) are involved in this process. This study i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d3f9c686b6fbd8169e4c036456d36da
https://doi.org/10.1007/s11011-018-0224-4